Neurological Complications at Stroke Patients With Diabetes Mellitus
NCT ID: NCT01172977
Last Updated: 2011-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2010-08-31
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Automatic PredICtion of Edema After Stroke
NCT04057690
Prehospital Transcranial Duplex in Patients With Acute Stroke
NCT01069276
Endothelial Function and Progenitor Cells in Acute Ischemic Stroke
NCT01289795
Giessen Stroke Registry
NCT05295862
Early Neurological Trajectory and Clinical Outcomes in Brain Acute Ischemic Stroke
NCT06170086
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study has a high practical importance because any consequences in the treatment of diabetes mellitus can be implemented without affecting costs.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HbA1c ≤ 7
Stroke patients with mild diabetes mellitus HbA1c ≤ 7
No interventions assigned to this group
HbA1c ≥ 7,5
Stroke patients with severe diabetes mellitus HbA1c ≥ 7,5
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnant patients
* Patients with sensory aphasia
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Evangelisches Krankenhaus Bielefeld gGmbH
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Barzu Cristian
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cristian Barzu, MD
Role: PRINCIPAL_INVESTIGATOR
Evangelisches Krankenhaus Bielefeld, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Evangelisches Krankenhaus
Bielefeld, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DRKS00000470
Identifier Type: OTHER
Identifier Source: secondary_id
EvKB Barzu
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.